Search
for
Sort by
Research 31–60 of 131
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Carbamazepine-Induced Hair Loss
- Drug eruptions in dermatology
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- An overview of management of drug-induced hair and nail disorders
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Is there a role for dermatologists in eating disorders?
- Autoimmune thyroid disease and human health: a systematic review of Mendelian randomization studies
- A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Cutaneous Reactions to Drugs
- Aging Skin: A Window to the Body
- Risk of Type 2 Diabetes Mellitus in New Users of 5-Alpha Reductase Inhibitors: A Nationwide Historical Cohort Study
- Expanding the Senior-Løken syndrome spectrum: Combined Rothmund-Thomson features unveil the distinct Teelwani Syndrome phenotype
- Adrenal causes of endocrine hypertension in childhood or adolescence
- Cutaneous Manifestations of Lupus Erythematosus
- The necessity of investigations to clarify sex and racial disparities in pathophysiology of Long COVID
- Vitamins
- Clinical aspects of the metabolic syndrome
- ANDROGENETIC ALOPECIA
- The spectrum of nephrocutaneous diseases and associations
- Scalpel, Toxin, and Performance Pressure: Metabolic, Psychiatric, and Psychosocial Aspects of Aesthetic Medicine in Competitive and Physique Athletes
- Update on the dermatologic use of systemic glucocorticosteroids
- Holistic management plan for polycystic ovarian syndrome (PCOS): A systematic literature review
- Skin Disorders in Athletes: Professional and Recreational Sports
- Drug Information Analysis Service
- Lupus erythematosus: systemic and cutaneous manifestations
- Idiopathic Hirsutism*
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies